GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Cirrhosis Liver/VOCAL-Penn score
63

VOCAL-Penn score

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated December 1, 2025

The VOCAL-Penn score (VPS) is a medical risk prediction tool developed in 2021 to estimate postoperative mortality and decompensation risk in patients with cirrhosis undergoing surgical procedures. It is widely adopted in clinical practice, with over 15,000 users annually, and has been incorporated into major national and international society guidelines.

Key Features of the VOCAL-Penn Score:

  1. Purpose: The VPS helps clinicians assess the risks associated with surgery in patients with cirrhosis, a population that often faces higher surgical risks due to their complex medical condition.

  2. Clinical Use: The tool is designed to support surgical decision-making by providing accurate predictions of postoperative outcomes, enabling clinicians to better stratify risk and guide treatment plans.

  3. Adoption: Since its introduction, the VPS has achieved significant real-world uptake, indicating its utility and credibility among healthcare providers.

Factors Supporting Its Adoption:

The VOCAL-Penn score has been successful due to its alignment with five key design and implementation factors identified through clinician feedback:

  1. Efficiency: The tool is intuitive, requires minimal inputs, and integrates seamlessly into clinical workflows.

  2. Accessibility: Input variables are clinically meaningful and readily available, making the tool easy to use in practice.

  3. Transparency: The development process of the VPS is transparent, fostering trust among clinicians.

  4. Accuracy: Comparative performance data and external validations ensure the tool’s credibility and reliability.

  5. Generalizability: The score is applicable across diverse patient populations, supporting equitable use.

Context of Development:

The VPS was developed during a time when advancements in data science, electronic health records, and machine learning were driving the proliferation of medical prediction tools. Despite the availability of such tools, many faced challenges in achieving sustained clinical adoption due to usability and implementation issues. The VPS stands out as an example of a prediction model that successfully bridges the gap between statistical rigor and practical usability.

Research Insights:

A qualitative study involving 22 diverse clinicians who care for cirrhosis patients highlighted the importance of aligning risk prediction tools like the VPS with real-world clinical needs. Clinicians emphasized that tools should be easy to use, credible, and seamlessly integrated into existing workflows to encourage adoption.

Conclusion:

The VOCAL-Penn score serves as a model for designing effective medical risk prediction tools. By addressing practical factors such as efficiency, accessibility, transparency, accuracy, and generalizability, the VPS has achieved widespread use and has provided valuable insights for developing future tools. Its success demonstrates the importance of considering both statistical performance and real-world implementation needs in the design of clinical prediction models.

Related Q&A

64

Adrenal Dysfunction and HPA Axis Impairment in Decompensated Cirrhosis

Adrenal dysfunction (AD) and hypothalamic–pituitary–adrenal (HPA) axis impairment are important yet poorly understood phenomena in patients with decompensated cirrhosis, particularly in stable, non-hospitalized individuals. The study you referenced...

65

Incidence and Clinical Significance of Recompensation After HCV Cure

The incidence and clinical significance of recompensation after hepatitis C virus (HCV) cure in patients with decompensated cirrhosis have been a focus of detailed analysis. Here is a...

66

Early Hepatic Encephalopathy After TIPS Is Associated With Reduced Survival

Yes, early hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) placement is strongly associated with reduced survival. This conclusion is supported by a large multicenter analysis involving...

67

AGA Clinical Practice Update on Ascites, Volume Overload, and Hyponatremia in Cirrhosis

The American Gastroenterological Association (AGA) Clinical Practice Update on Ascites, Volume Overload, and Hyponatremia in Cirrhosis provides evidence-based guidance on the management of these complications in patients with...

68

Circulating microbiome profiling in transjugular intrahepatic portosystemic shunt patients: 16S rRNA vs. shotgun sequencing

The study focused on comparing the performance of 16S rRNA sequencing and shotgun metagenomic sequencing for profiling the circulating microbiome in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS)...

69

ACLF—Contrasting Perspectives From the East and West

Acute-on-chronic liver failure (ACLF) is a severe condition characterized by acute decompensation in patients with chronic liver disease, accompanied by organ failures and high short-term mortality. However, the...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer